scholarly article | Q13442814 |
P953 | full work available at URL | http://cancerres.aacrjournals.org/cgi/content/abstract/52/13/3768 |
P698 | PubMed publication ID | 1352183 |
P50 | author | Clara D. Bloomfield | Q4793409 |
P2093 | author name string | T. Tsuruo | |
K. Gajl-Peczalska | |||
W. Jaszcz | |||
G. A. Niehans | |||
M. R. Wick | |||
R. T. Perri | |||
V. Brunetto | |||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunohistochemistry | Q899285 |
P304 | page(s) | 3768-3775 | |
P577 | publication date | 1992-07-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Immunohistochemical identification of P-glycoprotein in previously untreated, diffuse large cell and immunoblastic lymphomas | |
P478 | volume | 52 |
Q36555764 | 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1 |
Q38741291 | An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL. |
Q53950598 | Biology and modulation of multidrug resistance (MDR) in hematological malignancies. |
Q40708934 | Cellular models for multiple drug resistance in cancer |
Q40115005 | Construction of double suicide genes system controlled by MDR1 promoter with targeted expression in drug-resistant glioma cells |
Q39369429 | Morphonuclear characterization of drug resistance by means of digital cell-image analysis: an in vitro assessment |
Q40535284 | Multidrug resistance (MDR) genes in haematological malignancies |
Q41052675 | Multidrug resistance in cancer chemotherapy |
Q27024260 | P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review |
Q40630952 | P-glycoprotein, multidrug resistance and tumor progression |
Q45871082 | P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells |
Q55280540 | S100-positive histiocytes in T-cell-dependent area in human lymph nodes express P-glycoprotein. |
Q38756867 | The frequency and clinical relevance of multidrug resistance protein expression in patients with lymphoma |
Search more.